MALDI-TOF bacterial subtyping to detect antibiotic resistance.
Antibiotic resistance
Bacteroides fragilis
KPC
MALDI-TOF
MRSA
Mass spectrometry
Subtyping
cfiA
Journal
Clinical mass spectrometry (Del Mar, Calif.)
ISSN: 2376-9998
Titre abrégé: Clin Mass Spectrom
Pays: Netherlands
ID NLM: 101697500
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
05
02
2019
revised:
10
06
2019
accepted:
10
06
2019
entrez:
17
12
2021
pubmed:
14
6
2019
medline:
14
6
2019
Statut:
epublish
Résumé
The spread of bacterial resistance has been continuously increasing in the recent decade. Multi-drug resistant (MDR) bacteria now represent one of the most worrisome public health issues, as they seriously complicate the treatment of infections, often leaving few therapeutic options. Enterobacteria and
Identifiants
pubmed: 34917756
doi: 10.1016/j.clinms.2019.06.002
pii: S2376-9998(19)30034-0
pmc: PMC8669444
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3-8Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2019 The Association for Mass Spectrometry: Applications to the Clinical Lab (MSACL). Published by Elsevier B.V.
Déclaration de conflit d'intérêts
MC, ABP and SA have any conflicts of interest to disclose. Authors with financial interests or relationships to disclose are listed with their details below: MK is employee of Bruker Daltonik GmbH, manufacturer of the MALDI Biotyper system. Corresponding author confirms here the conflict of interest statements provided during the initial submission of the manuscript.
Références
Lancet Infect Dis. 2013 Sep;13(9):785-96
pubmed: 23969216
J Antimicrob Chemother. 2014 May;69(5):1155-7
pubmed: 24398342
Front Microbiol. 2013 Mar 14;4:48
pubmed: 23504089
J Med Microbiol. 2017 May;66(5):670-677
pubmed: 28504926
Front Microbiol. 2018 Nov 23;9:2854
pubmed: 30542332
J Med Microbiol. 2012 Dec;61(Pt 12):1784-1788
pubmed: 22956754
Clin Microbiol Infect. 2011 Mar;17(3):371-9
pubmed: 20456453
Clin Chem. 2015 Jan;61(1):100-11
pubmed: 25278500
Int J Med Microbiol. 2014 Nov;304(8):1018-23
pubmed: 25116838
Emerg Infect Dis. 2002 Feb;8(2):160-6
pubmed: 11897067
J Med Microbiol. 2011 Nov;60(Pt 11):1584-1590
pubmed: 21680764
Int J Antimicrob Agents. 2017 Aug;50(2):127-134
pubmed: 28647532
Ann Acad Med Singap. 2015 Jan;44(1):13-8
pubmed: 25703492
J Intern Med. 2015 May;277(5):501-12
pubmed: 25556628
Euro Surveill. 2014 Dec 11;19(49):
pubmed: 25523972
J Bacteriol. 1995 Sep;177(18):5270-5
pubmed: 7545155
Clin Pharmacol Ther. 2014 Aug;96(2):147-9
pubmed: 25056394
Virulence. 2017 May 19;8(4):427-439
pubmed: 27168451
Antimicrob Agents Chemother. 2012 Sep;56(9):4885-90
pubmed: 22777044
Clin Microbiol Infect. 2014 Sep;20(9):821-30
pubmed: 24930781
Clin Lab Med. 2013 Sep;33(3):589-609
pubmed: 23931840
N Engl J Med. 1998 Aug 20;339(8):520-32
pubmed: 9709046
Clin Infect Dis. 2017 Feb 1;64(3):257-264
pubmed: 28013264
Clin Microbiol Infect. 2014 Oct;20(10):949-53
pubmed: 25040923
Microbiology (Reading). 2000 May;146 ( Pt 5):1241-1254
pubmed: 10832652
Antimicrob Agents Chemother. 2014;58(2):654-63
pubmed: 24080646
Virulence. 2017 May 19;8(4):460-469
pubmed: 27593176
Trends Mol Med. 2012 May;18(5):263-72
pubmed: 22480775
Antimicrob Agents Chemother. 1986 Nov;30(5):645-8
pubmed: 3492173
J Clin Microbiol. 2014 Aug;52(8):2804-12
pubmed: 24850353
Int J Antimicrob Agents. 2012 Apr;39(4):283-94
pubmed: 22386741